|
2025
|
Invention
|
Antibody drug conjugates (adc) that bind to 191p4d12 proteins.
Antibody drug conjugates (ADC's) ... |
|
|
Invention
|
Pharmaceutical compositions comprising anti-191p4d12 antibody drug conjugates and methods of use ... |
|
2024
|
Invention
|
Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjug... |
|
2023
|
Invention
|
Combination therapy of a pd-1 antagonist, a lag3 antagonist and an antibody drug conjugate that b... |
|
|
Invention
|
Combination therapy. Provided herein are methods of treating cancer, which comprise administering... |
|
|
Invention
|
Methods for treating patients with locally advanced or metastatic urothelial cancer with antibody... |
|
|
Invention
|
Antibodies that bind to axl proteins. Antibodies that bind to AXL protein and variants thereof ar... |
|
|
Invention
|
Antibody drug conjugates (adc) that bind to 158p1d7 proteins.
Antibody drug conjugates (ADC's) t... |
|
|
Invention
|
Methods for treating muscle invasive urothelial cancer or muscle invasive bladder cancer with ant... |
|
2022
|
Invention
|
Antibody drug conjugates (adc) that bind to 191p4d12 proteins.
Antibody drug conjugates (ADC’s) ... |
|
|
Invention
|
Methods for treating non-muscle invasive bladder cancer (nmibc) with antibody drug conjugates (ad... |
|
|
P/S
|
Providing healthcare information |
|
|
Invention
|
Derivatives of dolaproine-dolaisoleuine peptides.
Provided are peptide analogs, pharmaceutical c... |
|
2021
|
Invention
|
Methods for treating cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins. ... |
|
|
Invention
|
Markers for use in methods for treating cancers with antibody drug conjugates (adc).
Provided he... |
|
|
Invention
|
Markers for use in methods for treating cancers with antibody drug conjugates (adc). Provided her... |
|
2020
|
Invention
|
Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins.
Provide... |
|
|
Invention
|
Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins. Provided... |
|
|
Invention
|
Antibody drug conjugates (adc) that bind to 158p1d7 proteins. Antibody drug conjugates (ADC's) th... |
|
|
Invention
|
Antibody drug conjugates (adc) that bind to cd37 proteins. Antibody drug conjugates (ADC's) that ... |
|
|
Invention
|
Antibodies and molecules derived therefrom that bind to steap-1 proteins. Antibodies and molecule... |
|
2019
|
Invention
|
Derivatives of dolaproine-dolaisoleucine peptides. Provided are peptide analogs, pharmaceutical c... |
|
|
P/S
|
Business administration of health reimbursement arrangements; providing business information rega... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of cancer; pharmaceutical preparati... |
|
|
P/S
|
providing information and advice relating to pharmaceuticals, diseases and medical conditions and... |
|
|
P/S
|
pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparatio... |
|
2018
|
Invention
|
Antibody drug conjugates (adc) that bind to 161p2f10b proteins.
Antibody drug conjugates (ADC's)... |
|
|
Invention
|
Nectin-4 binding proteins and methods of use thereof. Provided herein are compositions, methods a... |
|
|
Invention
|
Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of ca... |
|
2017
|
Invention
|
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bla... |
|
2016
|
Invention
|
Psca: prostate stem cell antigen and uses thereof.
The invention provides a novel prostate cell-... |
|
|
Invention
|
Antibody drug conjugates (adc) that bind to flt3 proteins. Antibody drug conjugates (ADC's) that ... |
|
2014
|
Invention
|
Novel acid and corresponding protein entitled 161p2f10b useful in treatment and detection of canc... |
